Copper (U.S. formulation)
Scientific References >
Eniva Minerals for Life® copper occurs naturally in the earth as a pure metal, in various
rock minerals, as well as seawater. It is a trace mineral essential to plants, animals, and man. It is a cofactor in several important enzyme systems in the body, including superoxide dismutase (S.O.D.).
Minerals for Life® Copper is a liquid dietary supplement of the mineral Copper in aqueous
solution as an advanced proprietary molecular delivery system. A solution yields the smallest
particles the size of atoms, ions, or small molecules.
The purer the water the more efficiently minerals are activated into their electrically charged ionic state. Eniva uses OHM® water (multi-step purified water) in a unique proprietary process at Eniva's government-inspected manufacturing facility, yielding a bio-available form of Copper ions (Solutomic®) in sparkling clear solution for quicker absorption than tablets or capsules which must first dissolve in the digestive system before being absorbed.
Copper is of vital importance in the diet for many different reasons. Among these are its central role in promoting normal cardiovascular health and circulation, the formation and maintenance of strong bone mass, the inhibition of free radicals, and proper cell replication.* Copper is also vital in keeping blood vessels, skin and connective tissue supple and elastic. Various enzyme reactions also require copper.*
Copper Helps to Support:
- Healthy hair*
- Organ health*
- Joints, cartilage, and tendons*
- Healthy LDL and HDL cholesterol*
- Proper sugar levels*
- Calmness and positive outlook*
- Normal iron levels in body*
- Normal thyroid function*
Minerals for Life® Copper
Suggested Retail Price: $26.95
20 oz. - ID 8008
Supplement Facts |
Serving Size: 1 Teaspoon
Servings Per Container: 120 |
| |
Amount Per Serving |
% Daily Value |
Copper |
0.7 mg |
37% |
Ingredients: Purified water, copper (derived from copper sulfate).
Adult Directions:1 teaspoon daily with a meal.
Do not exceed 6 teaspoons daily.
No Stimulants, No Artificial Colors, No Artificial Flavors.
Caution: Do not consume if tamper resistant seal is broken or missing. Keep cap tightly closed and out of reach of children. Not intended for children under 14 years of age. Not for pregnant or lactating women. First consult with your physician before starting this or any new mineral or nutrient supplement program. Isolated minerals or nutrients are best taken as part of a comprehensive supplement program containing a broad spectrum of nutrients. |
Scientific References
Antholine WE. Kalyanaraman B. Petering DH. ESR of copper and iron complexes with antitumor and cytotoxic properties. Environmental Health Perspectives. 64:19-35, 1985.
Askari A, Long CL and Blakemore WS. Zinc, copper and parenteral nutrition in cancer: A review. J. Par. Ent. Nutr. 4:561-5571, 1980.
Berger MM. Cavadini C. Chiolero R. Dirren H. Copper, selenium, and zinc status and balances after major trauma. Journal of Trauma-Injury Infection & Critical Care. 40(1):103-9, 1996.
Berners-Price SJ. Johnson RK. Giovenella AJ. Faucette LF. Mirabelli CK. Sadler PJ. Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold. Journal of Inorganic Biochemistry. 33(4):285-95, 1988.
Caldwell JR. Venoms, copper, and zinc in the treatment of arthritis. Rheumatic Diseases Clinics of North America. 25(4):919-28, viiiix, 1999.
DiSilvestro RA. Marten J. Skehan M. Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free-living rheumatoid arthritis patients. Journal of the American College of Nutrition. 11(2):177-80, 1992.
Haiduc I. Silvestru C. Rhodium, iridium, copper and gold antitumor organometallic compounds. In Vivo. 3(4):285-93, 1989.
Ingraham RH. Kappel LC. Morgan EB. Srikandakumar A. Correction of subnormal fertility with copper and magnesium supplementation. Journal of Dairy Science. 70(1):167-80, 1987.
Kaler SG. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. American Journal of Clinical Nutrition. 67(5 Suppl):1029S-1034S, 1998.
Kaler SG. Menkes disease mutations and response to early copper histidine treatment. Nature Genetics. 13(1):21-2, 1996.
Kaler SG. Das S. Levinson B. Goldstein DS. Holmes CS. Patronas NJ. Packman S. Gahl WA. Successful early copper therapy in menkes disease associated with a mutant transcript containing a small In-frame deletion. Biochemical & Molecular Medicine. 57(1):37-46, 1996.
Kivirikko K and Peltonen L. Abnormalities in copper metabolism and disturbances in the synthesis of collagen and elastin. Med. Biol. 60:45-48, 1982.
Klevay LM, et al. Effects of a diet low in copper on a healthy man. Clinical Research. 28:758, 1980.
Lewis AJ. The role of copper in inflammatory disorders. Agents & Actions. 15(5-6):513-9, 1984.
Milanino R. Conforti A. Franco L. Marrella M. Velo G. Copper and inflammation-a possible rationale for the pharmacological manipulation of inflammatory disorders. Agents & Actions. 16(6):504-13, 1985.
Peretz A. Neve J. Famaey JP. Molle L. [Essential elements and rheumatic diseases. Physiopathologic aspects and therapeutic implications of copper, zinc and selenium]. [French] Journal de Pharmacie de Belgique. 42(6):395-403, 1987.
Pochon JP. Zinc- and copper-replacement therapy-a must in burns and scalds in children? Progress in Pediatric Surgery. 14:151-72, 1981.
Purice M. Soare G. Ionescu B. Dumitrache C. [The effect of zinc and copper in cases of male infertility]. [French] Endocrinologie. 28(3-4):171-86, 1990.
Reiser S, et al. Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr. Rep. Intl. 36:641-649, 1987.
Solomons NW. Biochemical, metabolic, and clinical role of copper in human nutrition. J. Am. Coll. Nutr. 4:83-105, 1985.
Sorenson JR. Antiinflammatory, analgesic, and antiulcer activities of copper complexes suggest their use in a physiologic approach to treatment of arthritic diseases. Basic Life Sciences. 49:591-4, 1988.
Sorenson JR. Copper complexes offer a physiological approach to treatment of chronic diseases. Progress in Medicinal Chemistry. 26:437-568, 1989.
Sorenson JR. Development of copper complexes for potential therapeutic use. Agents & Actions - Supplements. 8:305-25, 1981.
Sorenson JR. Soderberg LS. Chidambaram MV. de la Rosa DT. Salari H. Bond K. Kearns GL. Gray RA. Epperson CE. Baker ML. Bioavailable copper complexes offer a physiologic approach to treatment of chronic diseases. Advances in Experimental Medicine & Biology. 258:229-34, 1989.
Williams DM. Copper deficiency in humans. Seminars in Hematology. 20:118-128, 1983. |
